ClinicalTrials.Veeva

Menu

Various Strategies to Reduce Acute Post Hemorrhoidectomy Pain: A Comparative Study

Z

Zagazig University

Status

Active, not recruiting

Conditions

Acute Post Operative Pain

Treatments

Drug: light marcaine
Drug: ketorolac and light marcaine
Drug: Diclofenac Sodium Gel
Drug: Corticosteroids injection

Study type

Interventional

Funder types

Other

Identifiers

NCT06307106
#40\14-Jan-2024

Details and patient eligibility

About

Since post hemorrhoidectomy pain is a severe and common post operative symptom so there is a need to find a suitable method for reducing this pain, up to our knowledge, this the first study in ZUH to compare between ketrolac, light Marcaine, corticosteroids and diclofenac sodium injection at surgical site for relieve of post operative pain. This is a randomizes comparative prospective clinical trial.

Enrollment

120 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • both sex.
  • age from 18 to 60.

Exclusion criteria

  • patient refusal.
  • patients with associated ano-rectal diseases such as fissures, fistulas, ano-proctitis, recurrent or thrombosed hemorrhoids and ano-rectal malignancy.
  • patients with liver cell failure. patients unfit for surgery according to American Society of Anesthesiologists.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

120 participants in 4 patient groups

group A: ketorolac and light marcaine injection
Experimental group
Treatment:
Drug: ketorolac and light marcaine
group B: light marcaine injection
Experimental group
Treatment:
Drug: light marcaine
group C: corticosteroids injection
Experimental group
Treatment:
Drug: Corticosteroids injection
group D: topical diclofenac sodium
Experimental group
Treatment:
Drug: Diclofenac Sodium Gel

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems